glp-1 agonist or antagonist Schematic illustration of monoagonists, dual agonists and triple GLP-1-based therapies for type 2

Rise in early-onset type 2 diabetes The global epidemic of type 2 diabetes in younger people has contributed to an increase in type 2 diabetes during pregnancy, particularly among First Nations women and other marginalised population groups [45, 46]

Other benefits of ultra-long-acting GLP-1RAs include less fluctuation in blood concentration, improved gastrointestinal tolerance, and a simpler and more convenient once-a-week dosing regimen that improves the compliance of patients and the persistence of treatment (Gentilella et al., 2019)

FDA, U.S

Reducing fluid intake before bedtime, avoiding caffeine and alcohol, and practicing pelvic floor exercises can all help relieve symptoms